Взаимосвязь гипотиреоза и гиперпролактинемии
- Авторы: Шорманова Л.Ж.1, Габдильашимова З.Т.1, Хамидуллина З.Г.1, Ахмедьянова Г.У.1
-
Учреждения:
- НАО «Медицинский Университет Астана»
- Выпуск: № 12 (2022)
- Страницы: 46-49
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/250283
- DOI: https://doi.org/10.18565/aig.2022.209
- ID: 250283
Цитировать
Полный текст



Аннотация
Ключевые слова
Полный текст

Об авторах
Ляйля Жансултановна Шорманова
НАО «Медицинский Университет Астана»
Email: lyailyazhansultanovna@gmail.com
докторант PhD 1 курс
Зарема Толымбековна Габдильашимова
НАО «Медицинский Университет Астана»д.м.н., доцент кафедры акушерства и гинекологии №1
Зайтуна Гадиловна Хамидуллина
НАО «Медицинский Университет Астана»к.м.н., заведующая кафедрой акушерства и гинекологии №1
Гайныл Угубаевна Ахмедьянова
НАО «Медицинский Университет Астана»к.м.н., профессор кафедры акушерства и гинекологии №1
Список литературы
- Chiovato L., Magri F., Carle A. Hypothyroidism in eontext: where we've been and where we're going. Adv. Ther. 2019; 36(Suppl. 2): 47-58.
- Garmendia Madariaga A., Santos Palacios S., Guillen-Grima F., Galofre J.C. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab 2014; 99(3): 923-31. https://dx.doi.org/10.1210/jc.2013-2409.
- Гарднер Д., Шобек Д. Базисная и клиническая эндокринология. М.: БИНОМ; 2011. 304c.
- Chaker L., Bianco A.C., Jonklaas J., Peeters R.P. Hypothyroidism. Lancet. 2017; 390(10101): 1550-62. https://dx.oi.org/10.1016/S0140-6736(17)30703-1.
- Capozzi A., Scambia G., Pontecorvi A., Lello S. Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecol. Endocrinol. 2015; 31(7): 506-10. https://dx.doi.org/10.3109/09513590.2015.1017810.
- Samperi I., Lithgow K., Karavitaki N. Hyperprolactinaemia. J. Clin. Med. 2019; 8(12): 2203. https://dx.doi.org/10.3390/jcm8122203.
- Kars M., Souverein P.C., Herings R.M., Romijn J.A., Vandenbroucke J.P., de Boer A., Dekkers O.M. Estimated ageand sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia. J. Clin. Endocrinol. Metab. 2009; 94(8): 2729-34. https://dx.doi.org/10.1210/jc.2009-0177.
- Jacobs L.S., Snyder PJ., Wilber J.F. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (trh) in man. J. Clin. Endocrinol. Metab. 1971; 33(6): 996-8. https://dx.doi.org/10.1210/jcem-33-6-996.
- Bowers C.Y., Friesen H.G., Hwang P., Guyda H.J., Folkers К. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem. Biophys. Res. Commun. 1971; 45(4): 1033-41. https://dx.doi.org/10.1016/0006-291x(71)90441-4.
- Fox T.J., Anastasopoulou C. Pituitary hyperplasia in primary hypothyroidism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
- Katznelson L., Riskind P.N., Saxe V.C., Klibanski A. Prolactin pulsatile characteristics in postmenopausal women. J. Clin. Endocrinol. Metab. 1998; 83(3): 761-4. https://dx.doi.org/10.1210/jcem.83.3.4675.
- Олейник В.А., Эпштейн Е.В., Савран Е.В. Гиперпролактинемия и гипотиреоз (синдром Ван Вика-Росса-Геннеса). Проблемы эндокринологии. 1996; 42(1): 40-3.
- Honbo K.S., Van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am. J. Med. 1978; 64(5): 782-7. https://dx.doi.org/10.1016/0002-9343(78)90517-x.
- Notsu K., Ito Y., Furuya H., Ohguni S., Katoet Y. Incidence of hyperprolactinemia in patients with hashimoto's thyroiditis. Endocr. J. 1997; 44(1): 89-94. https://dx.doi.org/10.1507/endocrj.44.89.
- Sharma L.K., Sharma N., Gadpayle A.K., Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism. Eur. J. Intern. Med. 2016; 35: 106-10. https://dx.doi.org/10.1016/j.ejim.2016.07.012.
- Meier C., Christ-Crain M., Guglielmetti M., Huber P., Staub J., Mulleret B. Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy. Thyroid. 2003; 13(10): 979-85. https://dx.doi.org/10.1089/105072503322511391.
- Goel P., Kahkasha., Narang S., Gupta B.K., Goel K. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. J. Clin. Diagn. Res. 2015; 9(1): BC15-7. https://dx.doi.org/10.7860/JCDR/2015/9982.5443.
- Khorassanizadeh R., Sundaresh V., Levine S.N. Primary hypothyroidism with exceptionally high prolactin-A really big deal. World Neurosurg. 2016; 91: 675. e11-4. https://dx.doi.org/10.1016/j.wneu.2016.04.103.
- Гнадь Ю.Г. Сочетание гиперпролактинемии и субклинического гипотиреоза. Медицинский совет. 2009; 2: 42-4. [Gnad Y.G. The combination of hyperprolactinemia and subclinical hypothyroidism. Medical advice. 2009; 2:42-44. (in Russiаn)]]
- Sayki Arslan M., Sahin M., Topaloglu O., Tutal E., Karakose M., Gungunes A. et al. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin. Endocrinol. (Oxford). 2013; 79(6): 882-6. https://dx.doi.org/10.1111/cen.12217.
- Brand J.M., Frohn C., Cziupka K., Brockmann C., Kirchner H., Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw. 2004; 15(2): 99-104.
- Liu Y., Zhang Z., Jin Q., Liu Y., Kang Z., Huo Y. et al. Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets. Endocrine. 2019; 64(3): 648-56. https://dx.doi.org/10.1007/s12020-019-01896-y.
- Dogansen S.C., Selcukbiricik O.S., Bilir B.E., Yarman S. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas. Growth Horm. IGF Res. 2016; 29: 45-9. https://dx.doi.org/10.1016/j.ghir.2016.04.004.
- Elenkova A., Petrossians P., Zacharieva S., Beckers A. High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centre. Ann. Endocrinol. (Paris). 2016; 77(1): 37-42. https://dx.doi.org/10.1016/j.ando.2015.10.008.
- Elenkova A., Atanasova I., Kirilov G., Natchev Е., Ivanova R., Kovatcheva R. et al. Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study. Endocrine. 2017; 57(3): 486-93. https://dx.doi.org/10.1007/s12020-017-1372-8.
Дополнительные файлы
